Platform
Features
Pricing
0 followers
Visus Therapeutics is a clinical-stage company in pursuit of developing the world’s first presbyopia-correcting eye drop with the potential to last at least eight hours.
Industries
Headquarters
Employees
Links
Ben Bergo
9 members
8 members
4 members
3 members
Thermo Fisher Scientific
160 followers
Regeneron
92 followers
BeiGene
19 followers
Cytiva
10 followers
Tilda
1 follower
AbbVie
174 followers
Verve Therapeutics
54 followers
Tempus Labs
16 followers
Kodiak
2 followers
ReCode Therapeutics
Protagonist Therapeutics
Explore companies